Answers are grounded in this paper and cite their sources.
Eosinophilic bronchitis presents with chronic cough in children, suggesting inhaled corticosteroids can be effective.
Eosinophilic bronchitis is a clinical entity characterized by bronchial eosinophilic inflammation that clinically manifests only with chronic, essentially dry cough. Just like asthma, it responds well to inhaled corticosteroid therapy, but it differs in that it is not associated with airflow variability, bronchial hyperreactivity, or response to beta-2 agonists. Because of the absence of these peculiar features of asthma, it is now labelled with the acronym NAEB (“Non-Asthmatic Eosinophilic Bronchitis”). The essential histopathological difference with asthma lies in the location of mast cells: in asthma, they are mainly found in the smooth muscle of the bronchial wall, while in NAEB they are essentially located on the epithelial surface, adjacent to the sensory nerve endings involved in the cough reflex. NAEB is not uncommon and is well described in adults, but it is overlooked or only briefly mentioned in the paediatric literature, probably because of the common habit of paediatricians to think of asthma first in any child with persistent or unexplained cough. Although inhaled corticosteroid therapy proves equally effective, it is important to diagnose eosinophilic bronchitis correctly because of its different therapeutic and prognostic implications.
No takes yet. Share an insight, caveat, or question.
Longo et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: